ROBITUSSIN EXTRA STRENGTH COUGH CONTROL 200 MG / 5 ML
GUAIFENESIN : 200 MG / 5 ML DEXTROMETHORPHAN HYDROBROMIDE : 15 MG / 5 ML · DIN 02142775 · HALEON CANADA ULC
Health Canada status: MARKETED
What is ROBITUSSIN EXTRA STRENGTH COUGH CONTROL?
ROBITUSSIN EXTRA STRENGTH COUGH CONTROL 200 MG / 5 ML contains GUAIFENESIN : 200 MG / 5 ML DEXTROMETHORPHAN HYDROBROMIDE : 15 MG / 5 ML. It is listed in the Health Canada Drug Product Database under DIN 02142775, held by HALEON CANADA ULC, supplied as SYRUP for ORAL administration. Health Canada currently lists it as marketed, status dated 31-May-2024. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02142775 |
|---|---|
| Brand name | ROBITUSSIN EXTRA STRENGTH COUGH CONTROL |
| Generic / active ingredient | GUAIFENESIN : 200 MG / 5 ML DEXTROMETHORPHAN HYDROBROMIDE : 15 MG / 5 ML |
| Manufacturer | HALEON CANADA ULC |
| Strength | 200 MG / 5 ML |
| Dosage form | SYRUP |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | R05FA02 OPIUM DERIVATIVES AND EXPECTORANTS |
| AHFS class | 48:16.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 31-May-2024 |
| Original market date | 1995-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code R05FA02 OPIUM DERIVATIVES AND EXPECTORANTS. 25 of 156 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| BENYLIN EXTRA STRENGTH COUGH & CHEST CONGESTION | 200 MG / 5 ML | SYRUP | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | DIN 02265419 |
| BENYLIN EXTRA STRENGTH COUGH & CHEST CONGESTION WITH WARMING SENSATION | 15 MG / 5 ML | SYRUP | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | DIN 02003317 |
| BENYLIN EXTRA STRENGTH COUGH COMPLETE | 200 MG / 5 ML | SYRUP | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | DIN 02265400 |
| BENYLIN EXTRA STRENGTH FOR PEOPLE WITH DIABETES | 15 MG / 5 ML | SYRUP | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | DIN 02436485 |
| BENYLIN EXTRA STRENGTH MUCUS & PHLEGM PLUS COUGH CONTROL | 15 MG / 5 ML | SYRUP | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | DIN 02320959 |
| BENYLIN REGULAR STRENGTH COUGH PLUS CHEST CONGESTION RELIEF | 15 MG / 5 ML | SYRUP | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | DIN 01944762 |
| CALMYLIN | 12.5 MG / 5 ML | SYRUP | TEVA CANADA LIMITED | MARKETED | DIN 00535230 |
| CALMYLIN ACE | 10 MG / 5 ML | SYRUP | TEVA CANADA LIMITED | MARKETED | DIN 02198630 |
| CALMYLIN PSE WITH CODEINE | 3.3 MG / 5 ML | SYRUP | TEVA CANADA LIMITED | MARKETED | DIN 02172917 |
| COUGH & CHEST CONGESTION | 20 MG / 20 ML | SYRUP | JUNO OTC INC | MARKETED | DIN 02539195 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.